ArticleLeukemia research2025

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities.

J Preston Claiborne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.